INO vs MRO
Inovio Pharmaceuticals Inc (INO) versus MRO (MRO) — a side-by-side from cached financials, not a winner call.
Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
MRO (MRO) common stock.
Latest reported INO revenue for 2026-06-30 was $0. Net income was -$6.0M. INO currently screens at market cap $88.0M.
MRO does not have a complete income-statement cache yet.
INO currently screens at market cap $88.0M.
Not investment advice. Open the INO and MRO stock pages for the full models.
Not investment advice.